Investigating Temporal Improvements in Survival Following ST-elevation Myocardial Infarction.

Sponsor
University of Leeds (Other)
Overall Status
Completed
CT.gov ID
NCT03749694
Collaborator
(none)
232,353
113.9

Study Details

Study Description

Brief Summary

The aim of the study was to use data from the Myocardial Ischaemia National Audit Project (MINAP) to investigate whether temporal improvements in survival were associated with changes in patients' baseline clinical risk or use of guideline-indicated treatments for the management of STEMI, and to determine the extent to which associations explained the temporal improvements in survival.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    232353 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Investigating Temporal Improvements in Survival Following ST-elevation Myocardial Infarction: A Causal Mediation Analysis Using the Myocardial Ischaemia National Audit Project, 2004-2013.
    Actual Study Start Date :
    Jan 1, 2004
    Actual Primary Completion Date :
    Jun 30, 2013
    Actual Study Completion Date :
    Jun 30, 2013

    Outcome Measures

    Primary Outcome Measures

    1. All cause mortality [one year]

    Secondary Outcome Measures

    1. All cause mortality [six months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • aged 18 years or more

    • patients hospitalised with ST-elevation myocardial infarction

    Exclusion Criteria:
    • patients hospitalised with phenotypes other than ST-elevation myocardial infarction

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Leeds

    Investigators

    • Principal Investigator: Chris P Gale, FRCP, University of Leeds
    • Principal Investigator: Tatendashe B Dondo, PhD, University of Leeds
    • Principal Investigator: Marlous Hall, PhD, University of Leeds

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tatendashe Bernadette Dondo, Postdoctoral medical statistician, University of Leeds
    ClinicalTrials.gov Identifier:
    NCT03749694
    Other Study ID Numbers:
    • PG/13/81/30474_STEMI
    First Posted:
    Nov 21, 2018
    Last Update Posted:
    Nov 21, 2018
    Last Verified:
    Nov 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Tatendashe Bernadette Dondo, Postdoctoral medical statistician, University of Leeds
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 21, 2018